The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
Open accessAbstract
The diagnosis of invasive aspergillosis (IA) in patients with hematologic disorders is not straightforward; lack of sensitive and specific noninvasive diagnostic tests remains a major obstacle for establishing a precise diagnosis. In a series of 362 consecutive high-risk treatment episodes that were stratified according to the probability of IA based on recently accepted case definition sets, the potential for diagnosis of serial screening for circulating galactomannan (GM), a major aspergillar cell wall constituent was validated. After incorporating postmortem findings to allow a more accurate final analysis, this approach proved to have a sensitivity of 89.7% and a specificity of 98.1%. The positive and negative predictive values equaled 87.5% and 98.4%, respectively. False-positive reactions occurred at a rate of 14%, although this figure might be overestimated due to diagnostic uncertainty. More or less stringent criteria of estimation could highly influence sensitivity, which ranged from 100% to 42%; the impact on other test statistics was far less dramatic. All proven cases of IA, including 23 cases confirmed after autopsy only, had been detected before death, although serial sampling appeared to be necessary to maximize detection. The excellent sensitivity and negative predictive value makes this approach suitable for clinical decision making. Unfortunately, given the species-specificity of the assay, some emerging non-Aspergillus mycoses were not detected. In conclusion, serial screening for GM, complemented by appropriate imaging techniques, is a sensitive and noninvasive tool for the early diagnosis of IA in high-risk adult hematology patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer, J. G. (1999) · JAMA · doi:10.1001/jama.282.11.1061 · Cited by 1,861
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital
Groll, A. H., Shah, P. M., Mentzel, C., Schneider, M., Just-Nuebling, G., & Huebner, K. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)92700-0 · Cited by 778
Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J. F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.139 · Cited by 706
Therapeutic Outcome in Invasive Aspergillosis
Denning, D. W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.608 · Cited by 689
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S. (1997) · Clinical Infectious Diseases · doi:10.1086/513764 · Cited by 672
Treatment of Invasive Aspergillosis: Relation of Early Diagnosis and Treatment to Response
AISNER, J., SCHIMPFF, S. C., & WIERNIK, P. H. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-5-539 · Cited by 397
Maertens, J., Verhaegen, J., Demuynck, H., Brock, P., Verhoef, G., Vandenberghe, P., Van Eldere, J., Verbist, L., & Boogaerts, M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.10.3223-3228.1999 · Cited by 376
Self-citationOur Stubborn Quest for Diagnostic Certainty
Kassirer, J. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202211 · Cited by 375
Stynen, D., Goris, A., Sarfati, J., & Latgé, J. P. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.2.497-500.1995 · Cited by 330
The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323
Rat monoclonal antibodies against Aspergillus galactomannan
Stynen, D., Sarfati, J., Goris, A., Prévost, M. C., Lesourd, M., Kamphuis, H., Darras, V, & Latgé, J. P. (1992) · Infection and Immunity · doi:10.1128/iai.60.6.2237-2245.1992 · Cited by 267
Walsh, T. J., Hathorn, J. W., Sobel, J. D., Merz, W. G., Sanchez, V., Maret, S. M., Buckley, H. R., Pfaller, M. A., Schaufele, R., Sliva, C., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104113241504 · Cited by 248
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan
Swanink, C. M., Meis, J. F., Rijs, A. J., Donnelly, J. P., & Verweij, P. E. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.257-260.1997 · Cited by 222
Verweij, P. E., Stynen, D., Rijs, A. J., de Pauw, B. E., Hoogkamp-Korstanje, J. A., & Meis, J. F. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.7.1912-1914.1995 · Cited by 192
Sulahian, A., Tabouret, M., Ribaud, P., Sarfati, J., Gluckman, E., Latgé, J. P., & Derouin, F. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01591487 · Cited by 183
Statistical methods in microbiology
Ilstrup, D. M. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.3.219-226.1990 · Cited by 159
Value of antigen detection in predicting invasive pulmonary aspergillosis
Rogers, T. R., Haynes, K., & Barnes, R. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)92831-2 · Cited by 158
Rohrlich, P., Sarfati, J., Mariani‐Kurkdjian, P., Duval, M., Carol, A., Saint‐Martin, C., Bingen, É., LATGE, J.-P., & VILMER, E. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00011 · Cited by 149
Bretagne, S., Marmorat‐Khuong, A., Kuentz, M., Latgé, J., Bart–Delabesse, E., & Cordonnier, C. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)90833-1 · Cited by 129
Verweij, P. E., Weemaes, C. M. R., Curfs, J. H. A. J., Bretagne, S., & Meis, J. F. G. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3900-3901.2000 · Cited by 111
Early diagnosis of invasive aspergillosis
Denning, D. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)82003-6 · Cited by 89
Machetti, M., Feasi, M., Mordini, N., Lint, M. V., Bacigalupo, A. P., Latgé, J.-P., Sarfati, J., & Viscoli, C. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701206 · Cited by 88
Siemann, M., Koch‐Dörfler, M., & Gaude, M. (1998) · Mycoses · doi:10.1111/j.1439-0507.1998.tb00356.x · Cited by 86
Kaufman, L., Standard, P. G., Jalbert, M., & Kraft, D. E. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.9.2206-2209.1997 · Cited by 80
Developing Case Definitions for Symptom-based Conditions: the Problem of Specificity
Hyams, K. C. (1998) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017977 · Cited by 74
Ulusakarya, A., Chachaty, É., Vantelon, J., Youssef, A., Tancrède, C., Pico, J.-L., Bourhis, J.-H., Fenaux, P., & Munck, J. N. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200009 · Cited by 67
Problems in the Diagnosis of Invasive Fungal Diseases
Rinaldi, M. G. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.3.493 · Cited by 60
Two Strategies for Managing Invasive Aspergillosis: A Decision Analysis
Severens, J. L., Donnelly, J. P., Meis, J. F. G. M., Robbé, P. F. D. V., Pauw, B. E. D., & Verweij, P. E. (1997) · Clinical Infectious Diseases · doi:10.1086/516085 · Cited by 51
White, E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114458 · Cited by 50
Walsh, T. J., de Pauw, B., Anaissie, E. J., & Martino, P. (1994) · Medical Mycology · doi:10.1080/02681219480000711 · Cited by 44
The challenge of invasive aspergillosis: Increasing numbers in diverse patient groups
Verweij, P. E., & Denning, D. W. (1997) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(97)90083-7 · Cited by 23
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationDiagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis
Pfeiffer, C. D., Fine, J. P., & Safdar, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503427 · Cited by 962
Metadata
- Authors
- Maertens, J., Verhaegen, J., Lagrou, K., Van Eldere, J., & Boogaerts, M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-03-15
- Volume
- 97
- Issue
- 6
- Pages
- 1604-1610
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2040405627
- Cited by
- 513
- References
- 32
- FWCI
- 24.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.